3'-N-Acetylneuramin-lactose sodium salt manufacturers
|
| | 3'-N-Acetylneuramin-lactose sodium salt Basic information |
| Product Name: | 3'-N-Acetylneuramin-lactose sodium salt | | Synonyms: | NEU5AC-ALPHA2-3GAL-BETA1-4GLC;MONOFUCOSYL, MONOSIALYLLACTOSE;ALPHA-NEU5AC-[2->3]-BETA-D-GAL-[1->4]-D-GLC SODIUM SALT;II3NEUAC,I3FUC-LAC;O-(N-Acetyl-alpha-neuraminosyl)-(2-3)-O-beta-D-galactopyranosyl-(1-4)-D-glucose monosodium salt;3'-Sialyllactose Sodium Salt (synthetic);3'-Sialyllactose Sodium Salt from human milk;3'-Sialyllactose Sodium Salt > | | CAS: | 128596-80-5 | | MF: | C23H40NNaO19 | | MW: | 657.55 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File |  |
| | 3'-N-Acetylneuramin-lactose sodium salt Chemical Properties |
| Melting point | >180oC (dec.) | | storage temp. | −20°C | | solubility | Methanol (Slightly, Heated), Water (Slightly) | | form | Solid | | color | White to Off-White | | Stability: | Hygroscopic | | Cosmetics Ingredients Functions | SKIN CONDITIONING - MISCELLANEOUS | | InChIKey | PXGFDQDHNYOKKF-QQTUFLSENA-N |
| Hazard Codes | B | | WGK Germany | 3 | | F | 10-21 |
| | 3'-N-Acetylneuramin-lactose sodium salt Usage And Synthesis |
| Uses | 3''-Sialyllactose binds several viral strains, including strains of influenza, HIV-1, reovirus, and polyomavirus. | | in vivo | 3'-Sialyllactose sodium (10-100 mg/kg; p.o. three times a week for 6 weeks) protects mice against cartilage destruction from osteoarthritis[1].
3'-Sialyllactose sodium (500, 1000 and 2000 mg/kg; oral administration; once) induces no micronuclei in the bone marrow cells of mice[3].
3'-Sialyllactose sodium (oral administration; (500 to 1000 to 2000 mg/kg) every dose at 4-day intervals) shows the maximum tolerance dose (MTD) is greater than 2000 mg/kg in male and female beagle dogs[3].
3'-Sialyllactose sodium shows a lethal dose (LD50) above 20 g/kg bw, the highest dose tested[3]. | Animal Model: | 8-week-old male C57BL/6 mice with medial meniscus surgery[1] | | Dosage: | 10, 50 and 100 mg/kg | | Administration: | Oral gavage; 10-100 mg/kg three times a week; for 6 weeks | | Result: | Effectively protected osteoarthritis mice against cartilage destruction by catabolic factor expression.
|
|
| | 3'-N-Acetylneuramin-lactose sodium salt Preparation Products And Raw materials |
|